Xometry, Inc. (XMTR) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 7, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the XMTR SEC filings page.
Xometry, Inc. (XMTR) reported $686.6M in revenue for fiscal year 2025, up 25.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Xometry is scaling revenue with better operating efficiency, but reinvestment and a less conservative balance sheet mean growth has not yet become reported profit.
FY2025 changed the cash mechanics: operating cash flow moved from-$15.4M to$6.1M , yet free cash flow remained negative at-$24.1M . With capital expenditures of$30.2M , improved operating cash generation was absorbed by reinvestment rather than becoming excess cash.
Revenue reached
Despite the operating progress, net loss widened from
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Xometry, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Xometry, Inc. has an operating margin of -6.6%, meaning the company loses $7 on every $100 of revenue. This results in a profitability score of 30/100. This is up from -10.3% the prior year.
Xometry, Inc.'s revenue surged 25.9% year-over-year to $686.6M, reflecting rapid business expansion. This strong growth earns a score of 84/100.
Xometry, Inc. has a moderate D/E ratio of 1.55. This balance of debt and equity financing earns a leverage score of 37/100.
With a current ratio of 3.76, Xometry, Inc. holds $3.76 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 86/100.
While Xometry, Inc. generated $6.1M in operating cash flow, capex of $30.2M consumed most of it, leaving -$24.1M in free cash flow. This results in a low score of 15/100, reflecting heavy capital investment rather than weak cash generation.
Xometry, Inc. posts a -22.4% return on equity (ROE), meaning it loses $22 for every $100 of shareholders' equity. This results in a returns score of 38/100. This is down from -16.0% the prior year.
Xometry, Inc. scores 9.01, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($6.2B) relative to total liabilities ($427.0M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Xometry, Inc. passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.
Xometry, Inc. reported a net loss of $61.7M while generating $6.1M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Xometry, Inc. reported an operating loss of $45.5M against $4.9M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Xometry, Inc. generated $229.3M in revenue in Q2 2026. This represents an increase of 41.1% from the same quarter a year earlier. Against the prior quarter it is up 11.8%.
Xometry, Inc.'s EBITDA was $291K in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 105.0% from the same quarter a year earlier. Against the prior quarter it is up 200.7%.
Xometry, Inc. reported -$5.3M in net income in Q2 2026. This represents an increase of 79.9% from the same quarter a year earlier. Against the prior quarter it is down 1.0%.
Not reported for Q2 2026.
Cash & Balance Sheet
Xometry, Inc. held $21.8M in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
Xometry, Inc.'s gross margin was 38.0% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 2.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.3 percentage points.
Xometry, Inc.'s operating margin was -2.4% in Q2 2026, reflecting core business profitability. This is up 3.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.1 percentage points.
Xometry, Inc.'s net profit margin was -2.3% in Q2 2026, showing the share of revenue converted to profit. This is up 13.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.2 percentage points.
Xometry, Inc.'s ROE was -0.9% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 8.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.0 percentage points.
Capital Allocation
Xometry, Inc. invested $13.0M in research and development in Q2 2026. This represents an increase of 17.9% from the same quarter a year earlier. Against the prior quarter it is up 13.6%.
Not reported for Q2 2026.
Not reported for Q2 2026.
XMTR Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $229.3M+41.1% | $205.1M+35.9% | $192.4M+29.5% | $180.7M+27.5% | $162.5M+22.6% | $151.0M+23.1% | $148.5M+15.9% | $141.7M+19.1% |
| Cost of Revenue | $142.1M+46.0% | $126.7M+33.8% | $117.2M+30.9% | $108.7M+26.6% | $97.4M+22.1% | $94.6M+26.5% | $89.5M+13.2% | $85.9M+18.2% |
| Gross Profit | $87.2M+33.7% | $78.5M+39.3% | $75.2M+27.5% | $72.0M+29.0% | $65.2M+23.3% | $56.3M+17.6% | $59.0M+20.2% | $55.8M+20.7% |
| R&D Expenses | $13.0M+17.9% | $11.4M+2.3% | $12.1M+16.6% | $12.5M+34.0% | $11.0M+9.9% | $11.2M+16.5% | $10.4M+16.6% | $9.3M+9.6% |
| SG&A Expenses | $24.7M+45.9% | $20.7M+21.3% | $18.9M+7.8% | $19.5M+21.2% | $16.9M+2.8% | $17.0M+14.1% | $17.5M+21.1% | $16.1M+7.5% |
| Operating Income | -$5.5M+46.1% | -$5.2M+66.1% | -$8.8M+23.8% | -$11.1M+3.7% | -$10.3M+32.7% | -$15.4M+13.8% | -$11.5M+8.1% | -$11.5M+13.0% |
| EBITDA | $291K+105.0% | -$289K+97.4% | -$3.8M+53.7% | -$6.1M+26.7% | -$5.8M+51.8% | -$11.1M+24.2% | -$8.1M+14.9% | -$8.3M+23.5% |
| Interest Expense | $1.3M+6.4% | $1.3M+5.9% | $1.3M+6.0% | $1.3M+7.7% | $1.2M-0.5% | $1.2M-0.1% | $1.2M0.0% | $1.2M-1.5% |
| Income Tax | $354K+4525.0% | $248K | $614K+1597.6% | -$17K-156.7% | -$8K+20.0% | $0 | -$41K+92.7% | $30K-78.4% |
| Net Income | -$5.3M+79.9% | -$5.3M+65.1% | -$8.6M+13.1% | -$11.6M-13.7% | -$26.4M-93.0% | -$15.1M+9.3% | -$9.9M+6.5% | -$10.2M+15.2% |
Not reported in any period shown, so not listed: EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
XMTR Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.1B+54.0% | $740.3M+7.3% | $703.7M+3.5% | $698.9M+3.0% | $687.0M+1.2% | $690.1M-0.3% | $680.1M-3.9% | $678.2M-3.2% |
| Current Assets | $672.4M+104.7% | $364.1M+8.8% | $334.6M+2.2% | $341.1M+4.7% | $328.5M+0.3% | $334.6M-2.0% | $327.5M-8.1% | $325.7M-8.8% |
| Cash & Equivalents | $21.8M+29.9% | $21.0M+35.7% | $15.0M-32.5% | $20.8M+19.6% | $16.8M-24.1% | $15.5M-66.1% | $22.2M-58.4% | $17.4M-60.7% |
| Short-Term Investments | $494.9M+136.8% | $202.9M-6.0% | $204.1M-6.2% | $203.7M-6.0% | $209.0M-4.5% | $215.9M+3.7% | $217.6M+1.0% | $216.6M-6.8% |
| Inventory | $3.9M-16.3% | $3.6M-10.7% | $3.9M+0.1% | $4.2M+21.2% | $4.6M+61.4% | $4.0M+39.5% | $3.9M+35.7% | $3.5M+167.4% |
| Accounts Receivable | $130.3M+50.0% | $119.7M+40.0% | $97.4M+31.6% | $98.9M+25.9% | $86.9M+22.2% | $85.5M+23.4% | $74.0M+5.5% | $78.5M+22.8% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $263.5M-0.1% | $263.6M+0.2% | $263.8M+0.4% | $263.8M+0.3% | $263.8M+0.4% | $263.0M+0.1% | $262.7M-0.1% | $263.0M0.0% |
| Total Liabilities | $461.6M+11.1% | $457.1M+20.6% | $427.0M+17.1% | $425.8M+17.7% | $415.5M+14.9% | $379.1M+2.2% | $364.5M-3.3% | $361.8M-0.5% |
| Current Liabilities | $209.2M+149.0% | $204.4M+128.6% | $88.9M+18.9% | $94.1M+32.8% | $84.0M+19.2% | $89.4M+13.6% | $74.8M-10.1% | $70.9M+4.6% |
| Non-Current Liabilities | $252.4M-23.9% | $252.7M-12.8% | $338.0M+16.7% | $331.6M+14.0% | $331.5M+13.9% | $289.6M-0.9% | $289.7M-1.4% | $291.0M-1.7% |
| Total Equity | $595.0M+120.1% | $282.0M-9.0% | $275.6M-12.4% | $272.0M-13.7% | $270.4M-14.4% | $309.9M-3.3% | $314.5M-4.5% | $315.2M-6.1% |
| Retained Earnings | -$442.6M-7.5% | -$437.3M-13.5% | -$432.0M-16.7% | -$423.4M-17.5% | -$411.8M-17.6% | -$385.4M-14.5% | -$370.3M-15.8% | -$360.4M-17.7% |
Not reported in any period shown, so not listed: Long-Term Debt.
XMTR Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.9M+783.6% | $14.6M+496.2% | $4.4M-51.4% | $5.8M+259.4% | -$427K+95.3% | -$3.7M+68.5% | $9.1M+802.1% | -$3.6M+39.2% |
| Depreciation & Amortization | $5.8M+29.8% | $4.9M+16.1% | $5.0M+47.8% | $5.0M+55.6% | $4.5M+38.1% | $4.2M+34.7% | $3.4M+21.1% | $3.2M+34.6% |
| Stock-Based Compensation | $11.3M+43.7% | $8.3M+13.4% | N/A | $10.7M+54.6% | $7.9M-2.8% | $7.3M+21.6% | N/A | $7.0M+21.4% |
| Capital Expenditures | N/A | N/A | $10.3M+126.3% | $7.4M+54.9% | $7.0M+58.1% | $5.5M+26.5% | $4.5M-29.4% | $4.8M+34.7% |
| Free Cash Flow | N/A | N/A | -$5.9M-228.8% | -$1.7M+80.4% | -$7.4M+45.3% | -$9.2M+42.9% | $4.5M+158.9% | -$8.4M+11.6% |
| Investing Cash Flow | -$305.4M-206258.1% | -$9.3M-152.9% | -$10.7M-95.7% | -$2.1M+17.2% | -$148K+99.0% | -$3.7M-225.9% | -$5.4M-151.2% | -$2.6M+60.5% |
| Financing Cash Flow | $303.2M+19636.4% | $830K+62.7% | $384K-73.0% | $460K-67.6% | $1.5M+173.3% | $510K-58.6% | $1.4M+494.5% | $1.4M+400.0% |
| Share Buybacks | N/A | N/A | $0 | $0 | N/A | N/A | $0 | $0 |
Not reported in any period shown, so not listed: Dividends Paid.
XMTR Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 38.0%-2.1pp | 38.3%+1.0pp | 39.1%-0.6pp | 39.9%+0.5pp | 40.1%+0.2pp | 37.3%-1.7pp | 39.7%+1.4pp | 39.4%+0.5pp |
| Operating Margin | -2.4%+3.9pp | -2.5%+7.7pp | -4.6%+3.2pp | -6.1%+2.0pp | -6.3%+5.2pp | -10.2%+4.4pp | -7.8%+2.0pp | -8.1%+3.0pp |
| Net Margin | -2.3%+13.9pp | -2.6%+7.4pp | -4.5%+2.2pp | -6.4%+0.8pp | -16.3%-5.9pp | -10.0%+3.5pp | -6.7%+1.6pp | -7.2%+2.9pp |
| Return on Equity | -0.9%+8.9pp | -1.9%+3.0pp | -3.1%0.0pp | -4.3%-1.0pp | -9.8%-5.4pp | -4.9%+0.3pp | -3.1%+0.1pp | -3.2%+0.3pp |
| Return on Assets | -0.5%+3.4pp | -0.7%+1.5pp | -1.2%+0.2pp | -1.7%-0.2pp | -3.9%-1.8pp | -2.2%+0.2pp | -1.5%0.0pp | -1.5%+0.2pp |
| Current Ratio | 3.21-0.7x | 1.78-2.0x | 3.76-0.6x | 3.62-1.0x | 3.91-0.7x | 3.74-0.6x | 4.38+0.1x | 4.59-0.7x |
| Debt-to-Equity | 0.78-0.8x | 1.62+0.4x | 1.55+0.4x | 1.57+0.4x | 1.54+0.4x | 1.22+0.1x | 1.160.0x | 1.15+0.1x |
| Asset Turnover | 0.220.0x | 0.28+0.1x | 0.27+0.1x | 0.260.0x | 0.240.0x | 0.220.0x | 0.220.0x | 0.210.0x |
| FCF Margin | N/A | N/A | -3.0%-6.1pp | -0.9%+5.0pp | -4.5%+5.6pp | -6.1%+7.0pp | 3.1%+9.1pp | -6.0%+2.1pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Xometry, Inc. XMTR | FY2025 | $686.6M | -$61.7M | -9.0% | $6.2B | 48/100 |
| American Superconductor Corp AMSC | FY2026 | $299.2M | $133.8M | 44.7% | $1.5B | 58/100 |
| Standex International Corporation SXI | FY2026 | $891.6M | $104.6M | 11.7% | $3.6B | 64/100 |
| Enerpac Tool Group Corp. EPAC | FY2025 | $616.9M | $92.7M | 15.0% | $1.8B | 69/100 |
| Crane NXT, Co. CXT | FY2025 | $1.7B | $145.1M | 8.8% | $2.9B | 59/100 |
Where Xometry, Inc. Ranks
Frequently Asked Questions
What is Xometry, Inc.'s annual revenue?
Xometry, Inc. (XMTR) reported $686.6M in total revenue for fiscal year 2025. This represents a 25.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Xometry, Inc.'s revenue growing?
Xometry, Inc. (XMTR) revenue grew by 25.9% year-over-year, from $545.5M to $686.6M in fiscal year 2025.
Is Xometry, Inc. profitable?
No, Xometry, Inc. (XMTR) reported a net income of -$61.7M in fiscal year 2025, with a net profit margin of -9.0%.
What is Xometry, Inc.'s EBITDA?
Xometry, Inc. (XMTR) had EBITDA of -$26.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Xometry, Inc.'s gross margin?
Xometry, Inc. (XMTR) had a gross margin of 39.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Xometry, Inc.'s operating margin?
Xometry, Inc. (XMTR) had an operating margin of -6.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Xometry, Inc.'s net profit margin?
Xometry, Inc. (XMTR) had a net profit margin of -9.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Xometry, Inc.'s return on equity (ROE)?
Xometry, Inc. (XMTR) has a return on equity of -22.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Xometry, Inc.'s free cash flow?
Xometry, Inc. (XMTR) recorded an outflow of $24.1M in free cash flow during fiscal year 2025. This represents a 28.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Xometry, Inc.'s operating cash flow?
Xometry, Inc. (XMTR) generated $6.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Xometry, Inc.'s total assets?
Xometry, Inc. (XMTR) had $703.7M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Xometry, Inc.'s capital expenditures?
Xometry, Inc. (XMTR) invested $30.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Xometry, Inc. spend on research and development?
Xometry, Inc. (XMTR) invested $46.8M in research and development during fiscal year 2025.
What is Xometry, Inc.'s current ratio?
Xometry, Inc. (XMTR) had a current ratio of 3.76 as of fiscal year 2025, which is generally considered healthy.
What is Xometry, Inc.'s debt-to-equity ratio?
Xometry, Inc. (XMTR) had a debt-to-equity ratio of 1.55 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Xometry, Inc.'s return on assets (ROA)?
Xometry, Inc. (XMTR) had a return on assets of -8.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Xometry, Inc.'s P/E ratio?
Xometry, Inc. (XMTR) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $6.2B as of Oct 7, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Xometry, Inc.'s price-to-sales ratio?
Xometry, Inc. (XMTR) trades at 7.7x sales, its market capitalization divided by revenue of $807.5M revenue, trailing 12 months to June 30, 2026. The market capitalization is $6.2B as of Oct 7, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Xometry, Inc.'s Altman Z-Score?
Xometry, Inc. (XMTR) has an Altman Z-Score of 9.01, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Xometry, Inc.'s Piotroski F-Score?
Xometry, Inc. (XMTR) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Xometry, Inc.'s earnings high quality?
Xometry, Inc. (XMTR) reported a net loss of $61.7M while generating $6.1M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Xometry, Inc. cover its interest payments?
Xometry, Inc. (XMTR) reported an operating loss of $45.5M against $4.9M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Xometry, Inc.?
Xometry, Inc. (XMTR) scores 48 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.